Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85


Sirt1 is a tumor promoter in lung adenocarcinoma.

Chen X, Hokka D, Maniwa Y, Ohbayashi C, Itoh T, Hayashi Y.

Oncol Lett. 2014 Jul;8(1):387-393. Epub 2014 Apr 10.


Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.

Jang SH, Min KW, Paik SS, Jang KS.

J Clin Pathol. 2012 Aug;65(8):735-9. doi: 10.1136/jclinpath-2012-200685. Epub 2012 May 3.


Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma.

Kang Y, Jung WY, Lee H, Lee E, Kim A, Kim BH.

Korean J Pathol. 2012 Dec;46(6):523-31. doi: 10.4132/KoreanJPathol.2012.46.6.523. Epub 2012 Dec 26.


The expression and correlation of SIRT1 and Phospho-SIRT1 in colorectal cancer.

Zhang X, Chen S, Cheng M, Cao F, Cheng Y.

Int J Clin Exp Med. 2015 Jan 15;8(1):809-17. eCollection 2015.


Prognostic and Predictive Role of Sirtuin1 Expression in Lung Adenocarcinoma.

Wang J, Wang C.

Clin Lab. 2016 Oct 1;62(10):1989-1994. doi: 10.7754/Clin.Lab.2016.160317.


Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.

Zu G, Ji A, Zhou T, Che N.

Int J Surg. 2016 Feb;26:32-7. doi: 10.1016/j.ijsu.2016.01.002. Epub 2016 Jan 4. Review.


Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.

Noh SJ, Baek HA, Park HS, Jang KY, Moon WS, Kang MJ, Lee DG, Kim MH, Lee JH, Chung MJ.

Pathol Res Pract. 2013 Jun;209(6):365-70. doi: 10.1016/j.prp.2013.03.011. Epub 2013 Apr 15.


SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.

Zhao G, Cui J, Zhang JG, Qin Q, Chen Q, Yin T, Deng SC, Liu Y, Liu L, Wang B, Tian K, Wang GB, Wang CY.

Gene Ther. 2011 Sep;18(9):920-8. doi: 10.1038/gt.2011.81. Epub 2011 Jun 16.


Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance.

Feng AN, Zhang LH, Fan XS, Huang Q, Ye Q, Wu HY, Yang J.

Int J Surg Pathol. 2011 Dec;19(6):743-50. doi: 10.1177/1066896911412181. Epub 2011 Aug 24.


SIRT1 as a therapeutic target in inflammaging of the pulmonary disease.

Rahman I, Kinnula VL, Gorbunova V, Yao H.

Prev Med. 2012 May;54 Suppl:S20-8. doi: 10.1016/j.ypmed.2011.11.014. Epub 2011 Dec 8. Review.


SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.

Lovaas JD, Zhu L, Chiao CY, Byles V, Faller DV, Dai Y.

Prostate. 2013 Apr;73(5):522-30. doi: 10.1002/pros.22592. Epub 2012 Oct 4.


SIRT1 and p53, effect on cancer, senescence and beyond.

Yi J, Luo J.

Biochim Biophys Acta. 2010 Aug;1804(8):1684-9. doi: 10.1016/j.bbapap.2010.05.002. Epub 2010 May 13. Review.


Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.

Chung YR, Kim H, Park SY, Park IA, Jang JJ, Choe JY, Jung YY, Im SA, Moon HG, Lee KH, Suh KJ, Kim TY, Noh DY, Han W, Ryu HS.

Hum Pathol. 2015 Jul;46(7):1027-35. doi: 10.1016/j.humpath.2015.03.015. Epub 2015 Apr 15.


SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.

Chen HC, Jeng YM, Yuan RH, Hsu HC, Chen YL.

Ann Surg Oncol. 2012 Jun;19(6):2011-9. doi: 10.1245/s10434-011-2159-4. Epub 2011 Dec 7.


High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma.

Stenzinger A, Endris V, Klauschen F, Sinn B, Lorenz K, Warth A, Goeppert B, Ehemann V, Muckenhuber A, Kamphues C, Bahra M, Neuhaus P, Weichert W.

BMC Cancer. 2013 Oct 2;13:450. doi: 10.1186/1471-2407-13-450.


Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.

Tseng RC, Lee CC, Hsu HS, Tzao C, Wang YC.

Neoplasia. 2009 Aug;11(8):763-70.


HDAC4 stabilizes SIRT1 via sumoylation SIRT1 to delay cellular senescence.

Han X, Niu J, Zhao Y, Kong Q, Tong T, Han L.

Clin Exp Pharmacol Physiol. 2016 Jan;43(1):41-6. doi: 10.1111/1440-1681.12496.


Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.


Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation.

Kilic Eren M, Kilincli A, Eren Ö.

PLoS One. 2015 Apr 29;10(4):e0124837. doi: 10.1371/journal.pone.0124837. eCollection 2015.


Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.

Hao C, Zhu PX, Yang X, Han ZP, Jiang JH, Zong C, Zhang XG, Liu WT, Zhao QD, Fan TT, Zhang L, Wei LX.

BMC Cancer. 2014 Dec 18;14:978. doi: 10.1186/1471-2407-14-978.

Supplemental Content

Support Center